Does Clevatess have side effects?

Does Clevatess have side effects? Like most medications, Clevatess (estradiol and progesterone) can cause side effects, though not everyone experiences them. Understanding these potential effects helps patients make informed decisions about their hormone replacement therapy.

Common Clevatess Side Effects

The most frequently reported side effects of Clevatess include:

- Breast tenderness or swelling

- Headaches or migraines

- Nausea and stomach discomfort

- Bloating and fluid retention

- Mood changes or irritability

- Irregular bleeding or spotting

- Weight fluctuations

These effects typically occur as your body adjusts to the hormone therapy and often diminish over time.

Serious Side Effects to Monitor

While rare, some serious side effects require immediate medical attention:

Cardiovascular Risks

- Blood clots in legs or lungs

- Stroke symptoms (sudden weakness, vision changes)

- Heart attack signs (chest pain, shortness of breath)

Other Serious Concerns

- Severe abdominal pain

- Unusual vaginal bleeding

- Severe headaches with vision changes

- Signs of liver problems (yellowing of skin/eyes)

Risk Factors and Precautions

Certain factors may increase your risk of side effects, including:

- Age over 60

- History of blood clots or cardiovascular disease

- Smoking

- Obesity

- Family history of breast or ovarian cancer

Managing Side Effects

Most mild side effects can be managed through:

- Taking medication with food to reduce nausea

- Staying hydrated and maintaining regular exercise

- Following up regularly with your healthcare provider

- Reporting any concerning symptoms promptly

Your doctor may adjust your dosage or recommend alternative treatments if side effects become problematic. If you're considering Clevatess or experiencing concerning symptoms, consult your healthcare provider to discuss whether this treatment is right for your specific situation.

Was this helpful?

Discussion (0)

Your email is used only to verify your comment. We never publish it.